Digital Genome Market 2016 | Outlook, Growth By Top Companies, Regions, Types, Applications, Drivers, Trends & Forecasts by 2024

This global Digital Genome market report studies the industry based on one or more segments covering key players, types, applications, products, technology, end-users, and regions for historical data as well as provides forecasts for next few years.

Digital Genome Market size will likely surpass USD 45 billion by 2024; according to a new research report. Digital Genome Market With the advent of digital genomics, it has now become more feasible for a plethora of health challenges to be diagnosed rapidly, thereby generating a favorable scope of sorts for digital genome market across myriad geographies.

Increased adoption of personalized medicine aimed at identifying genomic markers of disease and prescribe drugs that specifically target the pathway will drive the digital genome market size. Growing emphasis on sensitivity and specificity of the gene sequencing instruments should also fuel industry growth.

In 2015, sequencing and analyzing instruments accounted for over 40% of digital genome market share. Technological innovation for development of novel instruments coupled with growing investments in genetic research will provide thrust to industry expansion. Sequencing chips should witness over 10% CAGR owing to continuous R&D in bioinformatics, microfluidics, enzymology, and nanotechnology providing innovative platforms for digital genome market growth.

Request a sample of this premium Digital Genome market Research Report @ https://www.marketstudyreport.com/request-a-sample/467589/

Biotechnology innovation has enabled development of genetically modified organisms (GMOs) in order to introduce specific improvements or traits. Successful production and commercialization of such modified organisms should stimulate business growth. Extensive applications in clinical diagnosis and research will also contribute to industry growth.

Effective disease management strategies for chronic ailments and growing number of private and public investments and grants are forecast to propel digital genome market growth over the forecast years.

Concerns pertaining to security and confidentiality of patient data, lack of experienced professional and complex return on investment structure may hamper the digital genome market growth. Increasing application of digital genomics in next generation sequencing and wide use of microbes in diagnostics industry will stimulate microbiology segment growth; the segment is anticipated to surpass USD 10 billion by 2024.

Request a discount on standard prices of this premium Digital Genome market Research Report at https://www.marketstudyreport.com/check-for-discount/467589/

Bio-pharmaceutical companies accounted for over 45% of digital genome market share due to increasing demand for targeted drug therapy. Growing usage trend for precision medicines should provide lucrative growth opportunities for segment growth.

U.S. digital genome market size accounted for over 80% of the North American revenue in 2015, mainly due to the presence of established healthcare infrastructure and advanced facilities for effective treatment and care. The successful completion of Human Genome Project (HGP) has attracted significant public and private initiatives, driving the business growth.

In 2015, Germany digital genome market size was valued at over USD 1.4 billion and is anticipated to witness considerable growth till 2024. Increasing investments by public and private companies for development of novel technologies should boost digital genome industry growth.

China digital genome market is set to witness over 10% CAGR owing to favorable government initiative for development of human genetic resources platform and increasing collaboration among research institutes for creation of genomic databases and biobanks.

Some of the players operating in this industry include Perkin Elmer, Qiagen, Illumina, Becton Dickinson, Agilent, Sigma Aldrich, Fluidigm, Pacific Biosciences, Veracyte, Trovagene, Affymetrix and Neogen. The industry participants are investing heavily in R&D to develop innovative products which would provide competitive advantage.

Some of the major players in sequencing and analysis instruments market include Life Technologies, Illumina, Thermo Fisher Scientific, and Roche. Few of the advanced sequencing technologies are Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent: proton/ PGM sequencing and SOLiD (sequencing by Oligonucleotide Ligation and Detection) sequencing.

The ability of digital genomics to diagnose chronic disorders and cancers has helped catapult this technology ahead, placing it among one of the best personalized treatments. With the help of digitalized facilities, doctors can now easily take decisions with regards to suitability of a specific treatment.
The potential of this testing to develop highly targeted therapies especially while treating cancer patients is poised to enhance digital genome market share. As per the estimates of World Health Organization (WHO), cancer is the second largest cause of deaths across the globe. WHO predicts nearly 8.8 million cancer patients to have lost their lives in 2015. The growing prevalence of cancer patients across the globe is slated to stimulate digital genome market share.

Outside of the scope digital technologies such as Internet of Things (IoT) and artificial intelligence (AI) have also had a positive influence on digital genome industry trends. Most of the regional governments are investing in the development of AI-based healthcare infrastructure related to genomics. AI platforms have the ability to streamline clinical workflow by analyzing genomic data and identifying important mutations which will preferably help doctors to treat patients with effective drugs. The ability of digital genomes to overcome the risk factors of many diseases aided by a change in DNA is poised to fuel product demand over the years ahead.

More Report At: http://www.openpr.com/news/archive/144590/marketstudyreport-com.html

Report Content
Chapter 1. Methodology and Scope
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model & forecast
1.1.3. Industry insights & validation
1.1.4. Scope, definitions & research assumptions
1.2. Data Sources
1.2.1. Primary
1.2.2. Secondary
Chapter 2. Executive Summary
2.1. Digital Genome industry 360 degree synopsis, 2012 - 2024 (USD Million)
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Application trends
2.1.4. End-use trends
2.1.5. Regional trends
Chapter 3. Digital Genome Industry Insights
3.1. Industry segmentation
3.2. Industry size and forecast, 2012 - 2024 (USD Million)
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Successful completion of the Human Genome Project
3.3.1.2. Increasing public-private investments, funds, and grants
3.3.1.3. Advances in biotechnology
3.3.1.4. Increased Application in clinical diagnosis
3.3.1.5. Rising use of personalized medicine
3.3.1.6. Rise in incidence and prevalence of chronic diseases
3.3.1.7. Reduced cost and high speed for DNA sequencing
3.3.2. Industry pitfalls & challenges
3.3.2.1. Unclear ROI of precision medicine
3.3.2.2. Lack of trained staff
3.4. Growth potential analysis
3.5. Porter's analysis
3.6. Technology landscape
3.6.1. Advent of novel technologies
3.7. Company market share analysis, 2015
3.7.1. Strategy dashboard
3.8. PESTEL analysis

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email:sales@marketstudyreport.com
Website:https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/
Connect with us:Google+ | LinkedIn | Twitter

This release was published on openPR.